Stewart Goldman Selected Research

Brain Stem Neoplasms (Brain Stem Tumor)

1/2022	Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG Registry.
11/2020	Convection-Enhanced Delivery of Enhancer of Zeste Homolog-2 (EZH2) Inhibitor for the Treatment of Diffuse Intrinsic Pontine Glioma.
2/2018	New therapeutic approaches for brainstem tumors: a comparison of delivery routes using nanoliposomal irinotecan in an animal model.
4/2012	Efficacy of vincristine administered via convection-enhanced delivery in a rodent brainstem tumor model documented by bioluminescence imaging.
4/2007	Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stewart Goldman Research Topics

Disease

58	Neoplasms (Cancer) 01/2022 - 04/2003
35	Brain Neoplasms (Brain Tumor) 01/2022 - 07/2006
34	Glioma (Gliomas) 05/2022 - 04/2007
20	Medulloblastoma 01/2022 - 01/2006
17	Diffuse Intrinsic Pontine Glioma 12/2022 - 03/2014
10	Ependymoma 01/2019 - 04/2010
9	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 02/2008
8	Central Nervous System Neoplasms 01/2016 - 07/2007
6	Neurofibromatoses (Neurofibromatosis) 01/2021 - 01/2017
5	Brain Stem Neoplasms (Brain Stem Tumor) 01/2022 - 04/2007
5	Fatigue 01/2021 - 07/2007
5	Plexiform Neurofibroma 01/2021 - 05/2014
5	Neurofibromatosis 1 (Neurofibromatosis Type I) 10/2020 - 05/2014
5	Hemorrhage 05/2015 - 01/2006
4	Astrocytoma (Pilocytic Astrocytoma) 01/2019 - 12/2008
3	Retinoblastoma (Glioblastoma, Retinal) 07/2010 - 03/2008
2	Pain (Aches) 01/2021 - 01/2021
2	Neutropenia 01/2021 - 04/2007
2	Craniopharyngioma (Craniopharyngiomas) 11/2020 - 04/2003
2	Exanthema (Rash) 01/2019 - 08/2017
2	Thrombocytopenia (Thrombopenia) 03/2016 - 02/2015
2	Chronic Disease (Chronic Diseases) 03/2016 - 07/2007
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 08/2015 - 09/2013
2	Nausea 02/2015 - 09/2014
2	Hypoxia (Hypoxemia) 01/2014 - 11/2012
2	Germinoma 09/2013 - 06/2008
2	Disease Progression 07/2010 - 03/2010
2	Sepsis (Septicemia) 07/2010 - 03/2010
2	Gliosarcoma 12/2009 - 05/2009
2	Residual Neoplasm 11/2009 - 12/2008
1	Teratoma (Teratoid Tumor) 11/2022
1	Cardiotoxicity 01/2022
1	Hypothyroidism 01/2021
1	Leukopenia 01/2021
1	Neoplasm Metastasis (Metastasis) 09/2020
1	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 09/2020

Drug/Important Bio-Agent (IBA)

18	dipinacoline glutamateIBA 12/2022 - 03/2014
12	Pharmaceutical PreparationsIBA 02/2018 - 02/2008
8	Bevacizumab (Avastin)FDA Link 03/2016 - 01/2010
5	Proteins (Proteins, Gene)FDA Link 01/2018 - 11/2011
5	Carboplatin (JM8)FDA LinkGeneric 03/2010 - 03/2008
4	Histones (Histone)IBA 11/2020 - 05/2014
4	Phosphotransferases (Kinase)IBA 01/2019 - 05/2016
4	Temozolomide (Temodar)FDA LinkGeneric 01/2019 - 11/2007
4	Irinotecan (Camptosar)FDA LinkGeneric 02/2018 - 11/2012
4	Etoposide (VP 16)FDA LinkGeneric 01/2017 - 03/2008
4	LuciferasesIBA 04/2012 - 05/2009
3	Everolimus FDA Link 01/2022 - 10/2020
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2021 - 08/2017
3	AZD 6244IBA 10/2021 - 08/2017
3	Eukaryotic Initiation Factor-4EIBA 01/2018 - 01/2014
3	DNA (Deoxyribonucleic Acid)IBA 11/2016 - 02/2008
3	Peptide Initiation Factors (Initiation Factor)IBA 10/2016 - 01/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2015 - 11/2012
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2014 - 02/2009
3	EnzymesIBA 09/2009 - 04/2007
2	Vorinostat FDA Link 01/2022 - 11/2009
2	VaccinesIBA 01/2022 - 12/2020
2	Retinoblastoma ProteinIBA 01/2021 - 11/2016
2	Mitogen-Activated Protein KinasesIBA 01/2021 - 08/2017
2	Biological ProductsIBA 01/2021 - 05/2012
2	palbociclibIBA 01/2021 - 11/2016
2	Cyclin-Dependent Kinase 4IBA 01/2021 - 11/2016
2	MTOR InhibitorsIBA 10/2020 - 09/2014
2	Lenalidomide (CC 5013)FDA Link 09/2020 - 01/2011
2	RE1-silencing transcription factorIBA 01/2019 - 08/2012
2	Protein Isoforms (Isoforms)IBA 01/2019 - 10/2016
2	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 01/2019
2	Small Interfering RNA (siRNA)IBA 05/2016 - 09/2014
2	HhAntag691IBA 08/2015 - 11/2013
2	Lapatinib (GW572016)FDA Link 05/2015 - 09/2013
2	Mechanistic Target of Rapamycin Complex 1IBA 09/2014 - 01/2014
2	Sirolimus (Rapamycin)FDA Link 09/2014 - 01/2014
2	CollagenIBA 09/2014 - 01/2006
2	Farnesyltranstransferase (Farnesyltransferase)IBA 05/2014 - 07/2007
2	Vincristine (Oncovin)FDA LinkGeneric 04/2012 - 01/2012
2	O(6)-benzylguanineIBA 02/2012 - 11/2007
2	MicroRNAs (MicroRNA)IBA 01/2011 - 03/2010
2	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 03/2010 - 12/2008
2	Clofarabine (Clolar)FDA Link 09/2009 - 04/2006
2	Anticonvulsants (Antiepileptic Drugs)IBA 02/2009 - 04/2007
1	Isotretinoin (Accutane)FDA LinkGeneric 01/2022
1	ribociclibIBA 01/2022
1	mirdametinibIBA 01/2021
1	CytokinesIBA 01/2021
1	cabozantinibIBA 01/2021
1	InterferonsIBA 11/2020
1	tazemetostatIBA 11/2020
1	TOR Serine-Threonine KinasesIBA 10/2020
1	Protons (Proton)IBA 11/2019

Therapy/Procedure

40	Therapeutics 11/2022 - 10/2005
20	Drug Therapy (Chemotherapy) 01/2022 - 03/2008
12	Radiotherapy 11/2020 - 04/2003
3	Immunotherapy 01/2021 - 01/2019
3	Craniospinal Irradiation 01/2021 - 08/2015
2	Proton Therapy 11/2019 - 04/2015
2	Neoadjuvant Therapy 01/2017 - 08/2015
1	Aftercare (After-Treatment) 01/2021
1	Drug Tapering 01/2021
1	X-Ray Therapy 11/2019